Today on the Internet
SEE OTHER BRANDS

Fresh internet news from the world

Today on the Internet: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today on the Internet.

Press releases published on October 18, 2025

Rising Global Demand for Next-Generation Casino Software Solutions
Ecer.com Leads the Mobile B2B Revolution in Global Trade
AV-Comparatives Publishes Consumer Antivirus Tests: Which Cybersecurity Software Keeps You Safe Without Slowing You Down
Crypto News (Live): From $0.0075 to $0.50? Blazpay’s AI Presale Heats Up as Solana and BNB Investors Seek New Gains
Free Welcome Bonus No Deposit Required Real Money Online Casino By Cafe Casino
Free Spins No Deposit Bonus Casino Canada By Cafe Casino
Crypto Casino No Deposit Bonus | Bitcoin Casino No Deposit Bonus 2025 By Cafe Casino
Free Spins No Deposit UK | Real Money Online Casino In UK By Cafe Casino
Fast Payout Casinos 2025: All iGaming Releases Exclusive Update on the Instant Withdrawal Casinos
Herpafend Addresses Herpes Outbreak Prevention as Natural Remedies Market Reaches $1.23 Billion
Sify Technologies to announce Financial Results for Second Quarter FY 2025-26 on Saturday, October 25, 2025
Empower Business Resilience with SOC as a Service for Advanced Cyber Defense
DeFi crypto Mutuum Finance (MUTM) Onboards Over 17,300 Investors With 70% of Phase 6 Allocated
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
Celcuity Presents Updated Data at the 2025 ESMO Congress from Phase 1 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration Resistant Prostate Cancer (“mCRPC”)
Detailed Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Presented at 2025 ESMO Congress Demonstrate Potential for Gedatolisib Regimens to be Practice Changing for Patients with HR+/HER2- Advanced Breast Cancer
Kura Oncology Announces Preliminary Data from Its Farnesyl Transferase Inhibitor (FTI) Programs at the 2025 European Society for Medical Oncology (ESMO) Congress
Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025
General Oncology Announces Promising Preliminary Phase 1 Results from SHARON Trial Presented at ESMO 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions